Neos Therapeutics was founded in 2008 and is headquartered in Grand Prairie, US

Neos Therapeutics has offices in Grand Prairie and Blue Bell

Grand Prairie, US (HQ)

2940 N. Highway 360

Blue Bell, US

130 1787 Sentry Pkwy W

Neos Therapeutics's revenue was reported to be $9.2 m in FY, 2016

USD

## Net income (Q1, 2017) | (17.1 m) |

## EBIT (Q1, 2017) | (15 m) |

## Market capitalization (25-Jul-2017) | 134.4 m |

## Cash (31-Mar-2017) | 43.7 m |

Neos Therapeutics's current market capitalization is $134.4 m.

USD | FY, 2015^{} | FY, 2016^{} |
---|---|---|

## Revenue | 3.8 m | 9.2 m |

## Revenue growth, % | 141% | |

## Cost of goods sold | 5.5 m | 11.4 m |

## Gross profit | (1.8 m) | (2.3 m) |

## Gross profit Margin, % | (46%) | (25%) |

## R&D expense | 11.9 m | 12.2 m |

## General and administrative expense | 7.5 m | 12.6 m |

## Operating expense total | 19.4 m | 24.8 m |

## EBIT | (26.6 m) | (76.4 m) |

## EBIT margin, % | (701%) | (835%) |

## Interest expense | (3.7 m) | (6.9 m) |

## Net Income | (30.8 m) | (83.3 m) |

USD | Q2, 2015^{} | Q3, 2015^{} | Q1, 2016^{} | Q2, 2016^{} | Q3, 2016^{} | Q1, 2017^{} |
---|---|---|---|---|---|---|

## Revenue | 1.5 m | 221 k | ||||

## Cost of goods sold | 2.3 m | 1.7 m | 2.3 m | 4.6 m | ||

## R&D expense | 2.1 m | 2.7 m | 2.3 m | 4.3 m | 2.9 m | 1.7 m |

## General and administrative expense | 1.7 m | 2.1 m | 3.6 m | 3.5 m | 3.1 m | 3.5 m |

## Operating expense total | 3.8 m | 4.8 m | 5.9 m | 7.8 m | 6.1 m | 5.3 m |

## EBIT | (4.5 m) | (7 m) | (11.9 m) | (24 m) | (23.7 m) | (15 m) |

## EBIT margin, % | (306%) | (3156%) | ||||

## Interest expense | (884 k) | (1 m) | (961 k) | (1.5 m) | (2.1 m) | (2.2 m) |

## Net Income | (5.8 m) | (9.4 m) | (12.6 m) | (26.5 m) | (25.8 m) | (17.1 m) |

USD | FY, 2015^{} | FY, 2016^{} |
---|---|---|

## Cash | 90.8 m | 24.4 m |

## Accounts Receivable | 1.2 m | |

## Inventories | 2.5 m | 5.8 m |

## Current Assets | 98.2 m | 55.3 m |

## PP&E | 5.1 m | 7.1 m |

## Total Assets | 122.5 m | 80.1 m |

## Accounts Payable | 4.8 m | 7.8 m |

## Total Debt | 34.2 m | 63.5 m |

## Current Liabilities | 15.9 m | 21.6 m |

## Non-Current Liabilities | 28.2 m | 60 m |

## Total Liabilities | 44.1 m | 81.7 m |

## Additional Paid-in Capital | 195.3 m | 198.8 m |

## Retained Earnings | (116.8 m) | (200.1 m) |

## Total Equity | 78.4 m | (1.5 m) |

## Debt to Equity Ratio | 0.4 x | -41 x |

## Debt to Assets Ratio | 0.3 x | 0.8 x |

## Financial Leverage | 1.6 x | -51.8 x |

USD | Q2, 2015^{} | Q3, 2015^{} | Q1, 2016^{} | Q2, 2016^{} | Q3, 2016^{} | Q1, 2017^{} |
---|---|---|---|---|---|---|

## Cash | 25.6 m | 102.9 m | 42.4 m | 41.9 m | 43.5 m | 43.7 m |

## Inventories | 1.7 m | 2.7 m | 2.5 m | 4.4 m | 5.7 m | 5.6 m |

## Current Assets | 29.7 m | 106.4 m | 93.1 m | 91.9 m | 72 m | 74.7 m |

## PP&E | 5.3 m | 5.2 m | 5.4 m | 6.8 m | 7 m | 7 m |

## Total Assets | 55.9 m | 131.1 m | 117.9 m | 117.7 m | 97.4 m | 99 m |

## Accounts Payable | 1.3 m | 2.4 m | 3.5 m | 3.3 m | 7.8 m | 7 m |

## Current Liabilities | 7 m | 13.2 m | 17.9 m | 16.8 m | 21.4 m | 26 m |

## Non-Current Liabilities | 37.6 m | 30.9 m | 33.5 m | 60.2 m | 60.1 m | 60.4 m |

## Additional Paid-in Capital | 5.1 m | 194.7 m | 195.9 m | 196.8 m | 197.8 m | 230 m |

## Retained Earnings | (98.1 m) | (107.7 m) | (129.4 m) | (155.9 m) | (181.7 m) | (217.2 m) |

## Total Equity | (93 m) | 87 m | 66.4 m | 40.7 m | 15.9 m | 12.6 m |

## Financial Leverage | -0.6 x | 1.5 x | 1.8 x | 2.9 x | 6.1 x | 7.9 x |

USD | FY, 2015^{} | FY, 2016^{} |
---|---|---|

## Net Income | (30.8 m) | (83.3 m) |

## Accounts Receivable | (2.2 m) | |

## Inventories | 2.5 m | (3.2 m) |

## Accounts Payable | 4.8 m | 3 m |

## Cash From Operating Activities | (70.6 m) | |

## Capital Expenditures | (3.6 m) | |

## Cash From Investing Activities | (19.3 m) | |

## Cash From Financing Activities | 23.6 m | |

## Interest Paid | 2.9 m | |

## Free Cash Flow | (74.2 m) |

USD | Q2, 2015^{} | Q3, 2015^{} | Q1, 2016^{} | Q2, 2016^{} | Q3, 2016^{} | Q1, 2017^{} |
---|---|---|---|---|---|---|

## Net Income | (5.8 m) | (9.4 m) | (12.6 m) | (26.5 m) | (25.8 m) | (17.1 m) |

## Inventories | 1.7 m | 2.7 m | 2.5 m | 4.4 m | 5.7 m | 5.6 m |

## Accounts Payable | 1.3 m | 2.4 m | 3.5 m | 3.3 m | 7.8 m | 7 m |

Y, 2017 | |
---|---|

## Financial Leverage | 7.9 x |